We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
-13.22%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.1B
AUM Growth
-$3.31B
(-16%)
Cap. Flow
-$374M
Cap. Flow
% of AUM
-2.19%
Top 10 Holdings %
Top 10 Hldgs %
19.96%
Holding
1,420
New
91
Increased
417
Reduced
597
Closed
121
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Stock Market ETF
VTI
|
+$69.4M |
| 2 |
Ulta Beauty
ULTA
|
+$54.9M |
| 3 |
Lockheed Martin
LMT
|
+$54M |
| 4 |
Advanced Micro Devices
AMD
|
+$53.7M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$53M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$52.3M |
| 3 |
Take-Two Interactive
TTWO
|
+$47.9M |
| 4 |
eBay
EBAY
|
+$44.3M |
| 5 |
Cardinal Health
CAH
|
+$35.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.22% |
| 2 | Healthcare | 14.4% |
| 3 | Financials | 10.22% |
| 4 | Consumer Discretionary | 8.43% |
| 5 | Industrials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
10x Genomics
TXG
$5.83B
| $303K | ﹤0.01% |
6,707
+1,657
| +33% | +$86K |
|
1002
First Financial Bankshares
FFIN
$4.94B
| $302K | ﹤0.01% |
7,701
+51
| +0.7% | +$2.09K |
|
1003
Hexcel
HXL
$8.28B
| $302K | ﹤0.01% |
5,795
-460
| -7% | -$25.2K |
|
1004
Sprott Physical Gold
PHYS
$14.7B
| $302K | ﹤0.01% |
21,380
| – | – |
|
1005
Choice Hotels
CHH
$5.15B
| $300K | ﹤0.01% |
2,693
+844
| +46% | +$110K |
|
1006
Alnylam Pharmaceuticals
ALNY
$37.2B
| $298K | ﹤0.01% |
+2,044
| New | +$290K |
|
1007
Timken Company
TKR
$9.81B
| $292K | ﹤0.01% |
5,534
-28
| -0.5% | -$1.64K |
|
|
WPCB
1008
DELISTED
Warburg Pincus Capital Corporation I-B
WPCB
| $287K | ﹤0.01% |
29,330
| – | – |
|
1009
AptarGroup
ATR
$8.51B
| $286K | ﹤0.01% |
2,777
+155
| +6% | +$16.9K |
|
1010
Invesco
IVZ
$13.3B
| $284K | ﹤0.01% |
17,668
+183
| +1% | +$3.46K |
|
1011
Schwab US Dividend Equity ETF
SCHD
$103B
| $284K | ﹤0.01% |
11,934
+7,317
| +158% | +$186K |
|
1012
Omega Flex
OFLX
$305M
| $283K | ﹤0.01% |
2,637
-217
| -8% | -$24.6K |
|
1013
Global X Internet of Things ETF
SNSR
$216M
| $283K | ﹤0.01% |
+11,025
| New | +$316K |
|
|
ALCE
1014
DELISTED
Alternus Clean Energy Inc
ALCE
| $283K | ﹤0.01% |
+1,158
| New | +$285K |
|
1015
Franco-Nevada
FNV
$41.4B
| $280K | ﹤0.01% |
2,135
+10
| +0.5% | +$1.48K |
|
1016
KKR & Co
KKR
$91.3B
| $280K | ﹤0.01% |
6,074
+1,864
| +44% | +$97.8K |
|
|
KVSA
1017
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
| $279K | ﹤0.01% |
28,646
| – | – |
|
|
LFG
1018
DELISTED
Archaea Energy Inc.
LFG
| $279K | ﹤0.01% |
18,000
| – | – |
|
|
CMRC
1019
Commerce.com Inc Series 1
CMRC
$234M
| $278K | ﹤0.01% |
17,207
-2,748
| -14% | -$50.3K |
|
1020
Moderna
MRNA
$22.1B
| $278K | ﹤0.01% |
1,956
+27
| +1% | +$3.86K |
|
1021
Welltower
WELL
$175B
| $278K | ﹤0.01% |
3,389
-782
| -19% | -$69.6K |
|
1022
Copart
CPRT
$27.6B
| $277K | ﹤0.01% |
+10,224
| New | +$291K |
|
1023
DigitalBridge
DBRG
$2.93B
| $276K | ﹤0.01% |
14,160
+4
| +0% | +$98 |
|
1024
Maximus
MMS
$3.2B
| $275K | ﹤0.01% |
4,414
-4,441
| -50% | -$300K |
|
1025
Vanguard Extended Market ETF
VXF
$30.5B
| $275K | ﹤0.01% |
2,101
-2,836
| -57% | -$413K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q2 2022 Portfolio in Review
As of Q2 2022, Glenmede Trust held 1,420 positions worth $17.1B, down 16% from $20.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Glenmede Trust's Q2 2022 filing shows 91 new, 417 increased, 597 reduced and 121 closed positions. Its largest new stake was Pinterest: 974,820 shares worth $17.7M. The largest sale was Accenture, an estimated $53M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Glenmede Trust's largest Q2 2022 buy was Pinterest: 974,820 shares worth $17.7M.
- Glenmede Trust added most to Vanguard Total Stock Market ETF in Q2 2022, an estimated $69.4M increase.
- Glenmede Trust's biggest Q2 2022 reduction was Accenture, cutting an estimated $53M.
- Glenmede Trust fully exited Ovintiv in Q2 2022, selling an estimated $35M.
- Glenmede Trust's ten largest holdings make up 20% of its $17.1B portfolio in Q2 2022.
- Glenmede Trust opened 91 new positions and closed 121 in Q2 2022.
- Glenmede Trust's portfolio value fell 16% quarter-over-quarter to $17.1B.
Based on Glenmede Trust's 13F filing for Q2 2022, filed 15 Aug 2022.